Home

 

Indice/Contents Nº 11

UTILIDAD DE LA MEDICIÓN DE PERMEABILIDAD ALVEOLOCAPILAR CON Tc99m-DTPA EN EL COMPROMISO PULMONAR DE PACIENTES PORTADORES DEL VIRUS DE INMUNODEFICIENCIA ADQUIRIDA.

 

BIBLIOGRAFIA

 

1.-Centers for Disease Control: Classification system for Human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Morbid Mortal Weekly Rep 1986;35:334.

2.-Centers for Disease Control. Kaposi`s sarcoma and Pneumocystis pneumonia among homosexual men. New York City and California. Morbid Mortal Weekly Rep 1981;30:305-308

3.-Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbid Mortal Weekly Rep 1987,36s:3-16

4.-Hoover DR, Saah AJ, Bacellar H Phair J, Detels R et al. Clinical manifestations of AIDS in the era of neumocystis prophylaxis. N Engl J Med 1993;329;1922-1926

5.- Nieman RB, Fleming J, Coker RJ, Harris JR, Mitchell DM. Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS. Thorax 1993;48:481-485

6.- Bustamante EA, Levy H. Sputum induction compared with bronchoalveolar lavage by Ballard catheter to diagnose Pneumocystis Carinii pneumonia. Chest 1994;105:816-822.

7.-Golden J, Sollito R. The Radiology of Pulmonary Disease. Chest Radiography, Computed Tomography and gallium scaning. Pulmonary effects of AIDS. Clin Chest Med 1988;9:481-495

8.-DeLorenzo L, Tang Huang C, Maguire G, Stone D. Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS. Chest 1987;91:323-327.

9.-Massardo T, Humeres P. Efectos de la contaminacion atmosférica sobre la permeabilidad alveolocapilar usando Tc99m-DTPA. Rev Chil Enf Resp 1991;7:206-214.

10.-Kramer E. PCP, AIDS and Nuclear Medicine J Nucl Med 1994;35:1034-1037

11.-Vanarthos W, Ganz W, Vanarthos J, Serafini A, Tehranzadeh J. Diagnostic uses of Nuclear Medicine in AIDS. Radiographics 1992;4:731-752

12.-Tu JV, Biem HG, Detsky AS. Bronchoscopy versus empirical therapy in HIV infected patients with presumptive Pneumocystis carinii pneumonia. A decision analysis. Am Rev Resp Dis 1993; 148: 370-377

13.-Kirshembaum K, Burke R, Fanapour F, Lapat K, Overbeeke C, Blatt D, Sukerkar A, Cavallino RJ et al. Pulmonary high-resolution computed tomography versus gallium scintigraphy: diagnostic utility in the diagnosis of patients with AIDS who have chest symptoms and normal or equivocal chest radiographs. J Thoracic Imaging 1998;13:52-57.

14.-Jones DK, Higenbottam TW. Pneumocystis Pneumonia Increases the clearence rate of inhalated 99mTc-DTPA from lung to blood. Chest 1985;88:631-632.

15.-Miller RF. Nuclear Medicine and AIDS. Eur J Nucl Med 1990;16: 103-118

16.- Rosso J, Guillon JM, Parrot A, Denis M, Akoun C, Mayaud C et al.Technetium-99m-DTPA Aerosol and Gallium-67 Scanning in Pulmonary Complications of Human Immunodeficency Virus Infection. J Nucl Med 1992;33:81-87

17.-Picard C, Meignan M, Rosso J,Cinotti L, Mayaud C, Revuz J. Technetium 99mTc-DTPA aerosol and Gallium scaning in Adquired Inmune deficiency Syndrome. Clin Nucl Med 1987;2:501-506.

18.-Mason G, Duane G, Mena I, Effros M. Accelerated solute clearance in Pneumocystis carinii Pneumonia. A. Rev. Respir. Dis 1987; 135: 864-868.

19.O'Doherty MJ, Page CJ, Bradbeer CS, Shamanesh M, Edwards , Burlow D et al. The place of lung 99m TcDTPA aerosol transfer in the investigation of lung infections in HIV positive patients. Respir Med 1989; 83:395-401

20.-Robinson DS, Cunningham DA, Dave S, Fleming J, Mitchell DM. Diagnostic value of lung clearance of Tc99m-DTPA compared with other non-invasive investigations in Pneumocystis carinii pneumonia in AIDS. Thorax 1991;46:722-726.

21.-Kohn H, Armbruster C, Konig B, Vetter N, Mostbeck A. Contribution to nuclear medicine to management of pulmonary complications in patiens with acquired immune deficiency. Acta Med Austriaca 1993;20:36-41

22.-Kvale PA, Rosen MJ, Hopewell PC Markowitz , Hansen N, Reichman LB et al. A decline in the pulmonary diffusing capacity does not indicate opportunistic lung disease in asymptomatic persons infected with the human immunodefficiency virus. Pulmonary complications of the HIV Infection Study group. Am Rev Resp Dis 1993;148: 390-395.

23.-Hartman TE, Primack SL, Muller NL Staples CA. Diagnosis of thoracic complications in AIDS: accuracy of CT. AJR 1994;162:547-553

24.-Lode H , Shaberg T. Rational approach to the diagnosis of Pneumocystis carinii pneumonia (PCP). Am J Public Health 1993;83:72-78

25.-Stover V, Meduri GU. Pulmonary function tests. Clinics in Chest Medicine 1988; 9:473-479

26.-Dimian CO, O´Doherty MJ, Asboe D, Page CJ, Entwisle K, Bingham JS. Radioactively labelled diethylene triamine penta acetate lung scan in Pneumocystis carinii pneumonia and asymptomatic HIV-positive patients. Int J STD AIDS 1997;8:482-488

27.-Jones JG, Minty BD, Lawler P, Hulands G, Crawley JC,Veall N. Increased Alveolar Epithelial Permeability in Cigarette Smokers. The Lancet 1980;12:66-67.

28.-Tashkin D, Kleerup E, Hoh CK, Kim Kj, Weber MM, Gil E. Effects of crack cocaine on pulmonary alveolar permeability. Chest 1997;112:327-335

 


Resumen /Abstract|Introducción | Material y Métodos | Resultados | Discusión | Bibliografía |Versión Completa| Portada Articulo